🔎 Trials Near Me

Utama › Sarkoma Tisu Lembut › Ohio › Columbus

Kajian klinikal Sarkoma Tisu Lembut di Columbus, OH

13 kajian untuk Sarkoma Tisu Lembut sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • dan 8 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06528769

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Mengambil pesertaFasa 1/2
  • Nationwide Children's Hospital, Columbus
Umur 12 hingga 40 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07725380

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Mengambil pesertaFasa 3
  • The James Cancer Hospital and Solove Research Institute, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06263231

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Mengambil pesertaKajian pemerhatian
  • OSU James Hospital, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT07377747

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Mengambil pesertaFasa 1/2
  • Ohio State University, Columbus
Umur 18 hingga 90 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06710756

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Mengambil pesertaFasa 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Mengambil pesertaKajian pemerhatian
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Feb 2026 · NCT02677961

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Mengambil pesertaFasa 1/2
  • Nationwide Children's Hospital, Columbus
Umur 2 hingga 30 · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05734066

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

Mengambil peserta
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Feb 2026 · NCT06500065

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Dis 2025 · NCT06943521

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Mengambil pesertaFasa 2
  • Nationwide Children's Hospital, Columbus
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Mengambil pesertaKajian pemerhatian
  • The Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Feb 2019 · NCT03838718

Kajian Sarkoma Tisu Lembut di bandar lain

Kajian lain di Columbus

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.